Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03536728
Title Oral AMXT 1501 Dicaprate in Combination With DFMO
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aminex Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Next Oncology - Austin Midtown Austin Texas 78758 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology - San Antonio San Antonio Texas 78240 United States Details
Virginia Cancer Center Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field